期刊文献+

肝脏特异性miR-122的分子生物学特性及功能 被引量:4

THE CHARACTERISTICS AND FUNCTIONS OF MOLECULAR BIOLOGY FOR LIVER-SPECIFIC miR-122
原文传递
导出
摘要 miR-122是在肝脏特异高表达的一种microRNA。研究表明:生理状态下,miR-122在调控肝脏的细胞发育、诱导细胞分化、调节细胞代谢、参与肝细胞应急应答等生命活动过程中发挥重要作用;而在病理状态下,miR-122与丙型肝炎病毒(HCV)和肝细胞肝癌(HCC)密切相关,可能促进HCVRNA复制,并在HCC发生、发展过程中发挥抑癌基因样作用,可能对HCC临床诊断和预后具有重要价值。鉴于miR-122参与调控肝脏生理及肝脏重大疾病的发生、发展等过程,文章详细阐述并讨论miR-122在肝脏中的生物学特性和功能,以及可能的作用机制。肝脏特异性miR-122有可能作为治疗人类肝脏疾病的关键靶点。 miR-122 is specifically and abundantly expressed in the human liver. The recent investigations have demonstrated that under the physiological condition, miR-122 may play important roles in regulating hepatocyte development, differentiation, metabolism, stress responses, and under the pathological condition, the abnormal expression of miR-122 is closely related to hepatitis C virus (HCV) or hepatocellular carcinoma (HCC), and miR-122 is likely to facilitate replication of HCV RNA or is as a tumor suppressor gene for hepatocarcinogenesis. In addition, miR-122 could have diagnostic and prognostic significance for HCC. Respecting the effects of miR-122 on the major diseases of the human liver, the authors reviewed and analyzed the biological characteristics, diverse functions and possible mechanisms of miR-122. This liver-specific microRNA, miR-122, could be exploited as a key target for the treatment of human liver diseases.
出处 《生物物理学报》 CAS CSCD 北大核心 2009年第3期183-191,共9页 Acta Biophysica Sinica
基金 863国家高技术研究发展计划(2008AA02Z109)资助 浙江省自然科学基金项目(Y2080304)~~
  • 相关文献

参考文献28

  • 1Jopling CL, Norman KL, Samow P. Positive and negative modulation of viral and cellular mRNAs by liver-specific microRNA miR-122. Cold Spring Harb Symp Quant Biol, 2006,71:369-376.
  • 2Girard M, Jacquemin E, Munnich A, Lyonnet S, Henrion-Caude A. miR-122, a paradigm for the role of microRNA in the liver. Journal of Hepatology, 2008,48(4): 648-659.
  • 3Moroy T, Marchio A, Etiemble J, Trepo C, Tiollais P, Buendia MA. Rearrangement and enhanced expression of c-myc in hepatocellular carcinoma of hepatitis virus infected woodchucks. Nature, 1986,324(6094):276-279.
  • 4Etiemble J, Moroy T, Jacquemin E, Tiollais P, Buendia MA. Fused transcripts of c-myc and a new cellular locus, hcr in a primary liver cancer. Oncogene, 1989,4(1):51-57.
  • 5Moroy T, Etiemble J, Bougueleret L, Hadchouel M, Tiollais P, Buendia MA. Structure and expression of hcr, a locus rearranged with c-myc in a woodchuck hepatocellular carcinoma. Oncogene, 1989,4(1):59-65.
  • 6Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T. Identification of tissue-specific microRNA from mouse. Curr Biol, 2002,12(9):735-739.
  • 7Chang J, Provost P, Taylor JM. Resistance of human hepatitis delta virus RNAs to Dicer activity. J Virol, 2003,77: 11910-11917.
  • 8Barrel DP, Chert CZ. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNA. Nat Rev Genet, 2004,5(5):396-400.
  • 9Chang J, Nicolas E, Marks D, Sander C, Lerro A, Buendia MA, Xu C, Mason WS, Moloshok T, Bolt R, Zaret KS, Taylor JM. miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol, 2004,1(2): 106-113.
  • 10Lewis BP, Shih IH, Joncs-ghoades MW, Barrel DP, Burge CB. Prediction of mammalian microRNA targets. Cell, 2003, 115(7):787-798.

同被引文献21

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部